Ubs Group Ag Acer Therapeutics Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$0.57 - $1.28 $34 - $78
61 Added 184.85%
94 $0
Q1 2023

May 12, 2023
SELL
$0.67 - $3.05 $911 - $4,148
-1,360 Reduced 97.63%
33 $0
Q4 2022

Feb 08, 2023
SELL
$1.13 - $4.15 $10,433 - $38,316
-9,233 Reduced 86.89%
1,393 $3,000
Q3 2022

Nov 10, 2022
BUY
$1.28 - $1.6 $13,559 - $16,948
10,593 Added 32100.0%
10,626 $15,000
Q1 2022

May 16, 2022
BUY
$1.98 - $2.98 $13 - $20
7 Added 26.92%
33 $0
Q4 2021

Feb 14, 2022
SELL
$1.88 - $2.9 $9,682 - $14,935
-5,150 Reduced 99.5%
26 $0
Q3 2021

Nov 15, 2021
BUY
$2.3 - $2.86 $6,686 - $8,314
2,907 Added 128.12%
5,176 $13,000
Q2 2021

Aug 13, 2021
SELL
$2.52 - $3.18 $1,176 - $1,485
-467 Reduced 17.07%
2,269 $6,000
Q1 2021

May 12, 2021
BUY
$2.47 - $4.39 $1,491 - $2,651
604 Added 28.33%
2,736 $9,000
Q4 2020

Feb 11, 2021
BUY
$2.34 - $2.99 $4,928 - $6,296
2,106 Added 8100.0%
2,132 $6,000
Q3 2020

Nov 12, 2020
BUY
$2.16 - $5.41 $32 - $81
15 Added 136.36%
26 $0
Q2 2020

Jul 31, 2020
SELL
$1.53 - $4.53 $15,823 - $46,849
-10,342 Reduced 99.89%
11 $0
Q1 2020

May 01, 2020
BUY
$1.18 - $5.86 $1,384 - $6,873
1,173 Added 12.78%
10,353 $21,000
Q4 2019

Feb 14, 2020
BUY
$2.85 - $4.2 $15,247 - $22,470
5,350 Added 139.69%
9,180 $37,000
Q3 2019

Nov 14, 2019
BUY
$1.95 - $3.93 $6,984 - $14,077
3,582 Added 1444.35%
3,830 $12,000
Q2 2019

Aug 14, 2019
BUY
$3.45 - $26.86 $855 - $6,661
248 New
248 $1,000
Q4 2018

Feb 14, 2019
SELL
$16.55 - $30.22 $37,667 - $68,780
-2,276 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$18.0 - $32.83 $15,246 - $27,807
847 Added 59.27%
2,276 $70,000
Q2 2018

Aug 14, 2018
BUY
$17.71 - $21.6 $25,307 - $30,866
1,429 New
1,429 $31,000
Q1 2018

May 15, 2018
SELL
$14.81 - $20.22 $19,800 - $27,034
-1,337 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$11.81 - $19.35 $15,789 - $25,870
1,337
1,337 $19,000

Others Institutions Holding ACER

# of Institutions
1
Shares Held
365
Call Options Held
0
Put Options Held
0
View Full List

About Acer Therapeutics Inc.

ACER Quotes by TradingView
  • Ticker ACER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,100,000
  • Description
  • Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...
More about ACER
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email